Trade Summary

2 days ago, Hayden Michael R, serving as Dir at AbCellera Biologics Inc. (ABCL), purchased 53,613 shares at $10.64 per share, for a total transaction value of $570,442.32. Following this transaction, Hayden Michael R now holds 1,373,397 shares of ABCL.

This purchase represents a 4.06% increase in Hayden Michael R's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, August 24, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 24, 2026 at 5:21 PM ET, meaning the disclosure happened on the same day as the trade.

AbCellera Biologics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.